U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Russia-Iran Military Alliance Deepens With Drone Shipments Amid Middle East Tensions
Tabletop particle accelerator could transform medicine and materials science
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Israel Eyes Litani River as New Border Amid Escalating Lebanon Offensive
Bachelet Pushes Forward With UN Secretary-General Bid Despite Chile's Withdrawal
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Denmark Election 2026: Frederiksen Eyes Third Term Amid Trump-Greenland Tensions 



